Integrated and clinical validation of helicase-like transcription factor as a biomarker for hepatocellular carcinoma. Ni Z, Gu J, Qiu Q, Li Y, et al. BMC Cancer 2026 Feb 2. doi: 10.1186/s12885-026-15652.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ni Z, Gu J, Qiu Q, Li Y, et al. Integrated and clinical validation of helicase-like transcription factor as a biomarker for hepatocellular carcinoma. BMC Cancer 2026 Feb 2. doi: 10.1186/s12885-026-15652.
PMID: 41629879